Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicalutamide and Dutasteride for Prostate Cytoreduction Prior to Brachytherapy
NCT00866554Phase 2Completed
- Sponsor
- CHU de Québec-Université Laval
- Start
- Mar 2009
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dutasteride in prostate cancer (PCa), sponsored by CHU de Québec-Université Laval. Started Mar 2009; status: completed.
02
Drugs
dutasteride
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00866554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00866554.